Einträge von Viardot, Andreas auf dem Publikationsserver

Mellert, Kevin, Benckendorff, Julian, Leithäuser, Frank, Zimmermann, Katarzyna, Wiegand, Peter, Frascaroli, Giada, Buck, Michaela, Malaise, Muriel, Hartmann, Gunther, Barchet, Winfried, Fürst, Daniel, Mytilineos, Joannis, Mayer-Steinacker, Regine, Viardot, Andreas und Möller, Peter (2020) U-DCS: characterization of the first permanent human dendritic sarcoma cell line. Scientific Reports 10 (1). Volltext nicht vorhanden.

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schäfer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josée M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Dührsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter und Engert, Andreas (2019) Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. Journal of Clinical Oncology 37 (31), S. 2835-2845. Volltext nicht vorhanden.

Zugmaier, Gerhard, Gökbuget, Nicola, Klinger, Matthias, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz-A., Marks, Reinhard, Faul, Christoph, Diedrich, Helmut, Reichle, Albrecht, Brüggemann, Monika, Holland, Chris, Schmidt, Margit, Einsele, Hermann, Bargou, Ralf C. und Topp, Max S. (2015) Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment. Blood 126 (24), S. 2578-2584. Volltext nicht vorhanden.

Hoelzer, Dieter, Walewski, Jan , Döhner, Hartmut, Viardot, Andreas, Hiddemann, Wolfgang, Spiekermann, Karsten, Serve, Hubert , Dührsen, Ulrich, Hüttmann, Andreas, Thiel, Eckhard, Dengler, Jolanta, Kneba, Michael, Schaich, Markus, Schmidt-Wolf, Ingo G. H., Beck, Joachim, Hertenstein, Bernd, Reichle, Albrecht, Domanska-Czyz, Katarzyna, Fietkau, Rainer, Horst, Heinz-August, Rieder, Harald, Schwartz, Stefan, Burmeister, Thomas und Gökbuget, Nicola (2014) Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood 124 (26), S. 3870-3879. Volltext nicht vorhanden.

Topp, Max S., Gökbuget, Nicola, Zugmaier, Gerhard, Klappers, Petra, Stelljes, Matthias, Neumann, Svenja, Viardot, Andreas, Marks, Reinhard, Diedrich, Helmut, Faul, Christoph, Reichle, Albrecht, Horst, Heinz-August, Brüggemann, Monika, Wessiepe, Dorothea, Holland, Chris, Alekar, Shilpa, Mergen, Noemi, Einsele, Hermann, Hoelzer, Dieter und Bargou, Ralf C. (2014) Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 32 (36), S. 4134-4140. Volltext nicht vorhanden.

Topp, Max, Goekbuget, Nicola, Zugmaier, Gerhard, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz-August, Reichle, Albrecht, Marks, Reinhard, Monika, Brueggemann, Ritgen, Matthias, Klappers, Petra, Mergen, Noemi, Goebeler, Marie-Elisabeth, Einsele, Hermann, Hoelzer, Dieter und Bargou, Ralph (2012) Effect of anti-CD19 BiTE blinatumomab on complete remission rate and overall survival in adult patients with relapsed/refractory B-precursor ALL. Journal of Clinical Oncology 30 (15_sup), S. 6500. Volltext nicht vorhanden.

Goekbuget, Nicola, Beck, Joachim, Brueggemann, Monika, Burmeister, Thomas, Buss, Eike C., Frickhofen, Norbert, Huettmann, Andreas, Morgner, Anke, Reichle, Albrecht, Schmidt-Wolf, Ingo, Schwartz, Stefan, Serve, Hubert, Spriewald, Bernd M, Starck, Michael, Stelljes, Matthias, Viardot, Andreas, Wendelin, Knut und Hoelzer, Dieter (2012) Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL). Blood 120 (21), S. 1493. Volltext nicht vorhanden.

Gökbuget, Nicola, Stanze, Daniel, Beck, Joachim, Diedrich, Helmut, Horst, Heinz-August, Hüttmann, Andreas, Kobbe, Guido, Kreuzer, Karl-Anton, Leimer, Lothar, Reichle, Albrecht, Schaich, Markus, Schwartz, Stefan, Serve, Hubert , Starck, Michael, Stelljes, Matthias, Stuhlmann, Reingard, Viardot, Andreas, Wendelin, Knut, Freund, Mathias und Hoelzer, Dieter (2012) Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. Blood 120 (10), S. 2032-2041. Volltext nicht vorhanden.

Topp, Max S., Goekbuget, Nicola, Zugmaier, Gerhard, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz A., Reichle, Albrecht, Marks, Reinhard E, Brueggemann, Monika, Ritgen, Matthias, Klappers, Petra, Mergen, Noemi, Goebeler, Marie-Elisabeth, Einsele, Hermann, Hoelzer, Dieter und Bargou, Ralf (2011) Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial. Blood 118 (21), S. 252. Volltext nicht vorhanden.

Gökbuget, Nicola, Basara, Nadezda, Baurmann, Herrad, Beck, Joachim, Brüggemann, Monika, Diedrich, Helmut, Güldenzoph, Björn, Hartung, Gernot, Horst, Heinz-August, Hüttmann, Andreas, Kobbe, Guido, Naumann, Ralph, Ratei, Richard, Reichle, Albrecht, Serve, Hubert , Stelljes, Matthias, Viardot, Andreas, Wattad, Mohammed und Hoelzer, Dieter (2011) High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation. Blood 118 (13), S. 3504-3511. Volltext nicht vorhanden.

Schwaenen, Carsten, Viardot, Andreas, Berger, Hilmar, Barth, Thomas F. E., Bentink, Stefan, Döhner, Hartmut, Enz, Martina, Feller, Alfred C., Hansmann, Martin-Leo, Hummel, Michael, Kestler, Hans A. , Klapper, Wolfram, Kreuz, Markus, Lenze, Dido, Loeffler, Markus, Möller, Peter, Müller-Hermelink, Hans-Konrad, Ott, German, Rosolowski, Maciej, Rosenwald, Andreas, Ruf, Sandra, Siebert, Reiner, Spang, Rainer, Stein, Harald, Truemper, Lorenz, Lichter, Peter, Bentz, Martin und Wessendorf, Swen (2009) Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes, Chromosomes and Cancer 48 (1), S. 39-54. Volltext nicht vorhanden.

von Schilling, Christoph, Schwarz, Kathleen, Hess, Georg, Viardot, Andreas, Sandherr, Michael, Krause, Stefan, Simon, Jan P., Roethling, Nadine, Peschel, Christian, Schwaiger, Markus und Scheidhauer, Klemens (2007) Y-90 Ibritumomab Tiuxetan as Consolidation Following Three Cycles of Fludarabine-Cyclophosphamide-Rituximab Chemoimmunotherapy in Patients with Relapsed Follicular, Indolent or Mantle-Cell Lymphoma: A Prospective “Dose”-Finding Study. Blood 110 (11), S. 3426. Volltext nicht vorhanden.